8-K: Cosmos Health Faces Nasdaq Delisting Threat

Cosmos Health Inc. received a non-compliance letter from Nasdaq for failing to maintain its minimum bid price, facing potential delisting.

Summary

• Cosmos Health Inc. received a non-compliance letter from Nasdaq on December 11, 2025.
• The non-compliance is due to the company's failure to maintain a minimum bid price of $1.00 per share for thirty consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
• The company has 180 calendar days from December 11, 2025, to regain compliance.
• To regain compliance, the common stock's closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days.
• If compliance cannot be regained otherwise, the company intends to effect a reverse stock split.
• An indicator will be displayed with quotation information related to the company's securities.

Sentiment

Score: 3

Explanation: The company received a non-compliance notice from Nasdaq due to its low stock price, indicating significant operational or market challenges, though a plan to regain compliance is outlined.

Negatives

• Received a non-compliance letter from Nasdaq for failing to meet the minimum bid price requirement.
• Faces potential delisting from the Nasdaq Capital Market.
• May need to undertake a reverse stock split, which can be viewed negatively by investors.

Risks

• Risk of delisting from the Nasdaq Capital Market if compliance is not regained.
• Negative investor perception and potential stock price volatility due to the non-compliance notice.
• Potential for a reverse stock split, which can sometimes lead to further share price decline and reduced liquidity.
• An indicator will be displayed with quotation information, potentially highlighting the non-compliance to investors.

Future Outlook

The company intends to regain compliance with Nasdaq's minimum bid price rule within the 180-day period. If other methods are unsuccessful, management plans to effect a reverse stock split to meet the listing requirements.

Management Comments

• The company intends to effect a reverse stock split to regain compliance with the Listing Rule if it cannot otherwise regain compliance.

Industry Context

Receiving a non-compliance notice for minimum bid price is a common challenge for smaller-cap companies, particularly during periods of market downturn or company-specific underperformance. While a reverse stock split is a standard mechanism to address such issues and maintain listing, it often signals underlying operational or market challenges and can be met with skepticism by investors.

Comparison to Industry Standards

• Many small-cap companies on Nasdaq face similar minimum bid price challenges, especially those with limited trading volume or significant market capitalization declines.
• Reverse stock splits are a common strategy employed by companies like Cosmos Health to avoid delisting, a tactic seen across various industries when stock prices fall below exchange requirements.
• The 180-day compliance period is standard for Nasdaq's minimum bid price rule, aligning with the timeframe given to other companies in similar situations.

Stakeholder Impact

• Shareholders face potential delisting, which could reduce liquidity and investor interest.
• Shareholders may experience a reverse stock split, which reduces the number of outstanding shares and can sometimes lead to further price volatility.
• The non-compliance notice and potential delisting could negatively impact investor confidence and the company's ability to raise capital in the future.

Next Steps

• Regain compliance with Nasdaq Listing Rule 5550(a)(2) by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days within 180 calendar days from December 11, 2025.
• Potentially effect a reverse stock split if other methods fail to regain compliance.

Key Dates

Recommendation

The company's failure to meet Nasdaq's minimum bid price requirement and the potential need for a reverse stock split signal significant underlying operational or market challenges. This situation typically leads to increased volatility, negative investor sentiment, and potential further dilution or loss of liquidity, making it a high-risk investment with a strong likelihood of continued downward pressure.

Keywords

Cosmos Health, Nasdaq, Delisting, Minimum Bid Price, Reverse Stock Split, Compliance, 8-K